Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Subgroup analyses of the effect of ramucirumab in pretreatment with immune checkpoint inhibitor in RINDBeRG: A randomized clinical trial in third- or further-line treatment of gastric cancer.
Authors
Ryohei Kawabata
Osaka Rosai Hospital, and Sakai City Medical Center, Sakai, Osaka, Japan
Ryohei Kawabata , Daisuke Sakai , Shigenori Kadowaki , Takao Tsuduki , Takahisa Suzuki , Toru Masuzawa , Keitaro Shimozaki , Masahiro Tsuda , Takeshi Yamada , Toshifumi Yamaguchi , Shugo Ueda , Yosuke Kito , Toshiharu Hirose , Tomono Kawase , Takashi Nomura , Kazuhiro Nishikawa , Hisato Kawakami , Toshio Shimokawa , Narikazu Boku , Taroh Satoh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
jRCTs051180187
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 339)
DOI
10.1200/JCO.2024.42.3_suppl.339
Abstract #
339
Poster Bd #
F19
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Real-world effectiveness of drugs newly approved in Japan on survival in patients with advanced gastric cancer.
First Author: Toru Kadono
Poster
2020 Gastrointestinal Cancers Symposium
Correlation of tumor mutation with efficacy in patients with gastric cancer who received nivolumab and ramucirumab combination therapy.
First Author: Izuma Nakayama
Poster
2024 ASCO Annual Meeting
A phase I open-label study of a novel IL-2Rβ/γ cytokine agonist, LTC004, in patients with advanced or metastatic solid tumors.
First Author: Jifang Gong
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A scoring system for selecting nivolumab or irinotecan in the later-line chemotherapy for advanced gastric cancer: A Japanese multicenter retrospective study.
First Author: Yusuke Amanuma